Clinical Trial Update: Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir in patients with indolent B-cell lymphoma associated with hepatitis C; study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Indolent B-cell Lymphoma

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)
• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Indolent B-cell Lymphoma, Hepatitis C | Phase 2 | Status: COMPLETED